女性避孕藥市場：依避孕藥、避孕器具、配銷通路- 全球預測 2023-2030

預計到 2023 年，全球女性避孕藥具市場將大幅成長，達到 93.2221 億美元，年複合成長率為 6.39%，預計到 2030 年將達到驚人的 144.0402 億美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球女性避孕藥市場至關重要。透過檢視業務策略和產品滿意度的關鍵指標，我們對供應商進行全面評估，使用戶能夠根據自己的具體需求做出資訊的決策。這種進階分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市佔率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對總收入、基本客群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、累積和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、未開發領域、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通膨的累積影響。

5.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評估。

6. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1. 全球女性避孕藥市場規模及預測為何？

2.在預測期內，COVID-19對全球女性避孕藥具市場的阻礙因素與影響有哪些？

3. 在預測期內，全球女性避孕藥市場需要投資哪些產品/細分市場/用途/領域？

4.全球女性避孕藥市場的競爭策略是什麼？

5. 全球女性避孕藥市場的技術趨勢和法律規範是什麼？

6.全球女性避孕藥市場主要廠商的市佔率是多少？

7. 哪些型態和策略性措施被認為適合進入全球女性避孕藥市場？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

• 市場動態
  • 促進因素
    • 意外懷孕和性行為感染感染的發生率增加
    • 加強政府配合措施，提高人們對意外懷孕和人口成長的認知
    • 避孕藥具種類繁多且易於獲取
  • 抑制因素
    • 避孕藥的副作用
  • 機會
    • 避孕方法的可用性，例如植入式避孕藥和新型避孕藥
    • 政府和非政府組織支持新興經濟體避孕推廣計劃
  • 任務
    • 對各種避孕藥具的社會恥辱與誤解
• 市場趨勢
• COVID-19 的累積影響
• 俄羅斯-烏克蘭衝突的累積影響
• 高通膨的累積效應
• 波特五力分析
• 價值鍊和關鍵路徑分析
• 法律規範
• 客戶客製化

第6章 女性避孕藥市場：依避孕藥分類

• 介紹
• 避孕針劑
• 口服避孕藥
  • 荷爾蒙藥物
  • 非荷爾蒙藥物
• 殺精劑
• 局部避孕藥

第7章 女性避孕藥市場：依避孕器

• 介紹
• 避孕貼片
• 避孕海綿
• 隔膜和蓋子
• 女用保險套
• 避孕器
• 皮下植入避孕藥
• 避孕環

第8章 女性避孕藥市場：依配銷通路

• 介紹
• 診所
• 醫院藥房
• 獨立藥房
• 網路平台

第9章 美洲女性避孕藥市場

• 介紹
• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美國

第10章 亞太女性避孕藥市場

• 介紹
• 澳洲
• 中國
• 印度
• 印尼
• 日本
• 馬來西亞
• 菲律賓
• 新加坡
• 韓國
• 台灣
• 泰國
• 越南

第11章歐洲、中東和非洲女性避孕藥市場

• 介紹
• 丹麥
• 埃及
• 芬蘭
• 法國
• 德國
• 以色列
• 義大利
• 荷蘭
• 奈及利亞
• 挪威
• 波蘭
• 卡達
• 俄羅斯
• 沙烏地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公國
• 英國

第12章競爭形勢

• FPNV定位矩陣
• 市佔率分析：主要企業
• 競爭情境分析：主要企業

第13章上市公司名單

第14章附錄

• 討論指南
• 關於許可證和定價

The Global Female Contraceptive Market is forecasted to grow significantly, with a projected USD 9,322.21 million in 2023 at a CAGR of 6.39% and expected to reach a staggering USD 14,404.02 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Female Contraceptive Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Female Contraceptive Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Contraceptive Drug, market is studied across Contraceptive Injections, Contraceptive Pills, Spermicides, and Topical Contraceptives. The Contraceptive Pills is further studied across Hormonal Pills and Non-Hormonal Pills. The Topical Contraceptives is projected to witness significant market share during forecast period.

Based on Contraceptive Devices, market is studied across Contraceptive Patches, Contraceptive Sponges, Diaphragms & Caps, Female Condoms, Intra Uterine Contraceptive Devices, Sub-Dermal Contraceptive Implants, and Vaginal Rings. The Sub-Dermal Contraceptive Implants is projected to witness significant market share during forecast period.

Based on Distribution Channel, market is studied across Clinic, Hospital Pharmacy, Independent Pharmacy, and Online Platform. The Clinic is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Female Contraceptive Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Female Contraceptive Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Female Contraceptive Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Female Contraceptive Market?

4. What is the competitive strategic window for opportunities in the Global Female Contraceptive Market?

5. What are the technology trends and regulatory frameworks in the Global Female Contraceptive Market?

6. What is the market share of the leading vendors in the Global Female Contraceptive Market?

7. What modes and strategic moves are considered suitable for entering the Global Female Contraceptive Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Female Contraceptive Market, by Contraceptive Drug, 2022 vs 2030
• 4.3. Female Contraceptive Market, by Contraceptive Devices, 2022 vs 2030
• 4.4. Female Contraceptive Market, by Distribution Channel, 2022 vs 2030
• 4.5. Female Contraceptive Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing incidence of unwanted pregnancies and sexually transmitted diseases
    • 5.1.1.2. Rising government initiatives to promote awareness regarding unintended pregnancies and increasing population
    • 5.1.1.3. Multiple types and ease of availability of contraceptives
  • 5.1.2. Restraints
    • 5.1.2.1. Side effects of contraceptive drugs
  • 5.1.3. Opportunities
    • 5.1.3.1. Availability of contraceptives method such as Sino-Implants and novel contraceptive
    • 5.1.3.2. Government and non-government organizations supporting programs to encourage contraception in emerging economies
  • 5.1.4. Challenges
    • 5.1.4.1. Social stigma and misconceptions about different contraceptives
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Female Contraceptive Market, by Contraceptive Drug

• 6.1. Introduction
• 6.2. Contraceptive Injections
• 6.3. Contraceptive Pills
  • 6.3.1. Hormonal Pills
  • 6.3.2. Non-Hormonal Pills
• 6.4. Spermicides
• 6.5. Topical Contraceptives

7. Female Contraceptive Market, by Contraceptive Devices

• 7.1. Introduction
• 7.2. Contraceptive Patches
• 7.3. Contraceptive Sponges
• 7.4. Diaphragms & Caps
• 7.5. Female Condoms
• 7.6. Intra Uterine Contraceptive Devices
• 7.7. Sub-Dermal Contraceptive Implants
• 7.8. Vaginal Rings

8. Female Contraceptive Market, by Distribution Channel

• 8.1. Introduction
• 8.2. Clinic
• 8.3. Hospital Pharmacy
• 8.4. Independent Pharmacy
• 8.5. Online Platform

9. Americas Female Contraceptive Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Female Contraceptive Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Female Contraceptive Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. FPNV Positioning Matrix
• 12.2. Market Share Analysis, By Key Player
• 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

• 14.1. Discussion Guide
• 14.2. License & Pricing

LIST OF FIGURES

• FIGURE 1. FEMALE CONTRACEPTIVE MARKET RESEARCH PROCESS
• FIGURE 2. FEMALE CONTRACEPTIVE MARKET SIZE, 2022 VS 2030
• FIGURE 3. FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2022 VS 2030 (%)
• FIGURE 5. FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2022 VS 2030 (%)
• FIGURE 6. FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2030 (%)
• FIGURE 7. FEMALE CONTRACEPTIVE MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 8. FEMALE CONTRACEPTIVE MARKET DYNAMICS
• FIGURE 9. FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 10. FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 16. FEMALE CONTRACEPTIVE MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 17. FEMALE CONTRACEPTIVE MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. FEMALE CONTRACEPTIVE MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 5. FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE INJECTIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 7. FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL PILLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. FEMALE CONTRACEPTIVE MARKET SIZE, BY NON-HORMONAL PILLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. FEMALE CONTRACEPTIVE MARKET SIZE, BY SPERMICIDES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. FEMALE CONTRACEPTIVE MARKET SIZE, BY TOPICAL CONTRACEPTIVES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 13. FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PATCHES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE SPONGES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. FEMALE CONTRACEPTIVE MARKET SIZE, BY DIAPHRAGMS & CAPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. FEMALE CONTRACEPTIVE MARKET SIZE, BY FEMALE CONDOMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRA UTERINE CONTRACEPTIVE DEVICES , BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. FEMALE CONTRACEPTIVE MARKET SIZE, BY SUB-DERMAL CONTRACEPTIVE IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. FEMALE CONTRACEPTIVE MARKET SIZE, BY VAGINAL RINGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 21. FEMALE CONTRACEPTIVE MARKET SIZE, BY CLINIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. FEMALE CONTRACEPTIVE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. FEMALE CONTRACEPTIVE MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. FEMALE CONTRACEPTIVE MARKET SIZE, BY ONLINE PLATFORM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 34. BRAZIL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 35. BRAZIL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 36. BRAZIL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 38. CANADA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 39. CANADA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 40. CANADA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 41. CANADA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 42. MEXICO FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 43. MEXICO FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 44. MEXICO FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 45. MEXICO FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 46. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 47. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 48. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 49. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 50. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 51. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 52. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 53. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 54. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 55. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 56. AUSTRALIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 57. AUSTRALIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 58. AUSTRALIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 59. AUSTRALIA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 60. CHINA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 61. CHINA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 62. CHINA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 63. CHINA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 64. INDIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 65. INDIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 66. INDIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 67. INDIA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 68. INDONESIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 69. INDONESIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 70. INDONESIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 71. INDONESIA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 72. JAPAN FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 73. JAPAN FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 74. JAPAN FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 75. JAPAN FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 76. MALAYSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 77. MALAYSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 78. MALAYSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 79. MALAYSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 80. PHILIPPINES FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 81. PHILIPPINES FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 82. PHILIPPINES FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 83. PHILIPPINES FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 84. SINGAPORE FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 85. SINGAPORE FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 86. SINGAPORE FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 87. SINGAPORE FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH KOREA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 89. SOUTH KOREA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 90. SOUTH KOREA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 91. SOUTH KOREA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 92. TAIWAN FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 93. TAIWAN FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 94. TAIWAN FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 95. TAIWAN FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 96. THAILAND FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 97. THAILAND FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 98. THAILAND FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 99. THAILAND FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 100. VIETNAM FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 101. VIETNAM FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 102. VIETNAM FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 103. VIETNAM FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 104. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 105. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 106. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 107. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 108. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 109. DENMARK FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 110. DENMARK FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 111. DENMARK FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 112. DENMARK FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 113. EGYPT FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 114. EGYPT FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 115. EGYPT FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 116. EGYPT FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 117. FINLAND FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 118. FINLAND FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 119. FINLAND FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 120. FINLAND FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 121. FRANCE FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 122. FRANCE FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 123. FRANCE FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 124. FRANCE FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 125. GERMANY FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 126. GERMANY FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 127. GERMANY FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 128. GERMANY FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 129. ISRAEL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 130. ISRAEL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 131. ISRAEL FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 132. ISRAEL FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 133. ITALY FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 134. ITALY FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 135. ITALY FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 136. ITALY FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 137. NETHERLANDS FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 138. NETHERLANDS FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 139. NETHERLANDS FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 140. NETHERLANDS FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 141. NIGERIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 142. NIGERIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 143. NIGERIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 144. NIGERIA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 145. NORWAY FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 146. NORWAY FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 147. NORWAY FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 148. NORWAY FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 149. POLAND FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 150. POLAND FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 151. POLAND FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 152. POLAND FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 153. QATAR FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 154. QATAR FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 155. QATAR FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 156. QATAR FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 157. RUSSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 158. RUSSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 159. RUSSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 160. RUSSIA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 161. SAUDI ARABIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 162. SAUDI ARABIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 163. SAUDI ARABIA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 164. SAUDI ARABIA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 165. SOUTH AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 166. SOUTH AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 167. SOUTH AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 168. SOUTH AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 169. SPAIN FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 170. SPAIN FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 171. SPAIN FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 172. SPAIN FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 173. SWEDEN FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 174. SWEDEN FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 175. SWEDEN FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 176. SWEDEN FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 177. SWITZERLAND FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 178. SWITZERLAND FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 179. SWITZERLAND FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 180. SWITZERLAND FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 181. TURKEY FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 182. TURKEY FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 183. TURKEY FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 184. TURKEY FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 185. UNITED ARAB EMIRATES FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 186. UNITED ARAB EMIRATES FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 187. UNITED ARAB EMIRATES FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 188. UNITED ARAB EMIRATES FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 189. UNITED KINGDOM FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DRUG, 2018-2030 (USD MILLION)
• TABLE 190. UNITED KINGDOM FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE PILLS, 2018-2030 (USD MILLION)
• TABLE 191. UNITED KINGDOM FEMALE CONTRACEPTIVE MARKET SIZE, BY CONTRACEPTIVE DEVICES, 2018-2030 (USD MILLION)
• TABLE 192. UNITED KINGDOM FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 193. FEMALE CONTRACEPTIVE MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 194. FEMALE CONTRACEPTIVE MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 195. FEMALE CONTRACEPTIVE MARKET LICENSE & PRICING